These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26176812)

  • 1. MoFvAb: Modeling the Fv region of antibodies.
    Bujotzek A; Fuchs A; Qu C; Benz J; Klostermann S; Antes I; Georges G
    MAbs; 2015; 7(5):838-52. PubMed ID: 26176812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody modeling assessment.
    Almagro JC; Beavers MP; Hernandez-Guzman F; Maier J; Shaulsky J; Butenhof K; Labute P; Thorsteinson N; Kelly K; Teplyakov A; Luo J; Sweet R; Gilliland GL
    Proteins; 2011 Nov; 79(11):3050-66. PubMed ID: 21935986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody structure determination using a combination of homology modeling, energy-based refinement, and loop prediction.
    Zhu K; Day T; Warshaviak D; Murrett C; Friesner R; Pearlman D
    Proteins; 2014 Aug; 82(8):1646-55. PubMed ID: 24619874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution modeling of antibody structures by a combination of bioinformatics, expert knowledge, and molecular simulations.
    Shirai H; Ikeda K; Yamashita K; Tsuchiya Y; Sarmiento J; Liang S; Morokata T; Mizuguchi K; Higo J; Standley DM; Nakamura H
    Proteins; 2014 Aug; 82(8):1624-35. PubMed ID: 24756852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of VH-VL domain orientation for antibody variable domain modeling.
    Bujotzek A; Dunbar J; Lipsmeier F; Schäfer W; Antes I; Deane CM; Georges G
    Proteins; 2015 Apr; 83(4):681-95. PubMed ID: 25641019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
    Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
    J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting antibody complementarity determining region structures without classification.
    Choi Y; Deane CM
    Mol Biosyst; 2011 Dec; 7(12):3327-34. PubMed ID: 22011953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated Aufbau of antibody structures from given sequences using Macromoltek's SmrtMolAntibody.
    Berrondo M; Kaufmann S; Berrondo M
    Proteins; 2014 Aug; 82(8):1636-45. PubMed ID: 24777752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward high-resolution homology modeling of antibody Fv regions and application to antibody-antigen docking.
    Sivasubramanian A; Sircar A; Chaudhury S; Gray JJ
    Proteins; 2009 Feb; 74(2):497-514. PubMed ID: 19062174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The de novo design of an antibody combining site. Crystallographic analysis of the VL domain confirms the structural model.
    Essen LO; Skerra A
    J Mol Biol; 1994 Apr; 238(2):226-44. PubMed ID: 8158652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of an antibody model with an X-ray structure: the variable fragment of BR96.
    Bajorath J; Sheriff S
    Proteins; 1996 Feb; 24(2):152-7. PubMed ID: 8820482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canonical antigen-binding loop structures in immunoglobulins: more structures, more canonical classes?
    Decanniere K; Muyldermans S; Wyns L
    J Mol Biol; 2000 Jun; 300(1):83-91. PubMed ID: 10864500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of fully automated antibody homology modeling protocols in molecular operating environment.
    Maier JK; Labute P
    Proteins; 2014 Aug; 82(8):1599-610. PubMed ID: 24715627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
    Narayanan A; Sellers BD; Jacobson MP
    J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody modeling assessment II. Structures and models.
    Teplyakov A; Luo J; Obmolova G; Malia TJ; Sweet R; Stanfield RL; Kodangattil S; Almagro JC; Gilliland GL
    Proteins; 2014 Aug; 82(8):1563-82. PubMed ID: 24633955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced conformational diversity search of CDR-H3 in antibodies: role of the first CDR-H3 residue.
    Kim ST; Shirai H; Nakajima N; Higo J; Nakamura H
    Proteins; 1999 Dec; 37(4):683-96. PubMed ID: 10651282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of an isolated antibody VL domain.
    Constantine KL; Friedrichs MS; Metzler WJ; Wittekind M; Hensley P; Mueller L
    J Mol Biol; 1994 Feb; 236(1):310-27. PubMed ID: 8107112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for the homology modeling of antibody variable regions.
    Sircar A
    Methods Mol Biol; 2012; 857():301-11. PubMed ID: 22323227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ab initio structure prediction of the antibody hypervariable H3 loop.
    Zhu K; Day T
    Proteins; 2013 Jun; 81(6):1081-9. PubMed ID: 23255066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The third-dimensional structure of the complex between an Fv antibody fragment and an analogue of the main immunogenic region of the acetylcholine receptor: a combined two-dimensional NMR, homology, and molecular modeling approach.
    Kleinjung J; Petit MC; Orlewski P; Mamalaki A; Tzartos SJ; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Marraud M; Cung MT
    Biopolymers; 2000 Feb; 53(2):113-28. PubMed ID: 10679615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.